Javascript must be enabled to continue!
Acetone Metabolism During Diabetic Ketoacidosis
View through CrossRef
The presence and the importance of acetone and its metabolism in diabetic ketoacidosis has largely been ignored. Therefore, we studied acetone metabolism in nine diabetic patients in moderate to severe ketoacidosis.
The concentration of acetone in plasma, urine, and breath, and the rates of acetone production and elimination in breath and urine were determined and the rates of vivo metabolism were calculated. Plasma acetone concentrations (1.55–8.91 mM) were directly related and were generally > acetoacetate concentrations (1.16–6.08 mM). The rates of acetone production ranged from 68 to 581 μmol/min/1.73 m2, indicating the heterogeneous nature of the patients studied. The average acetone production rate was 265 μmol/min/1.73 m2 and accounted for about 52% of the estimated acetoacetate production rate. Urinary excretion of acetone remained constant and accounted for about 7% of the acetone production rate in all patients. There was a positive linear relationship between the percentage of the acetone production rate accounted for by excretion in breath and the plasma acetone concentration. At low plasma acetone concentrations, ∼ 20%, and at high plasma acetone concentrations, ∼ 80% of the production rate was accounted for by breath acetone. In contrast, there was a negative linear relationship between the percentage of acetone production rate undergoing in vivo metabolism and plasma acetone concentration. At low plasma acetone concentrations, ∼ 75%, and at high concentrations, ∼ 20% of acetone production rate was accounted for by in vivo metabolism. Radioactivity from 2-[14C]-acetone was variably present in plasma acetone, glucose, lipids and proteins. No radioactivity was found in plasma acetoacetate, beta-hydroxy butyrate or free fatty acids or other anionic compounds. Exchange rates of acetone into other metabolites could not be estimated because of non-steady-state precursor product relationships in these patients.
American Diabetes Association
Title: Acetone Metabolism During Diabetic Ketoacidosis
Description:
The presence and the importance of acetone and its metabolism in diabetic ketoacidosis has largely been ignored.
Therefore, we studied acetone metabolism in nine diabetic patients in moderate to severe ketoacidosis.
The concentration of acetone in plasma, urine, and breath, and the rates of acetone production and elimination in breath and urine were determined and the rates of vivo metabolism were calculated.
Plasma acetone concentrations (1.
55–8.
91 mM) were directly related and were generally > acetoacetate concentrations (1.
16–6.
08 mM).
The rates of acetone production ranged from 68 to 581 μmol/min/1.
73 m2, indicating the heterogeneous nature of the patients studied.
The average acetone production rate was 265 μmol/min/1.
73 m2 and accounted for about 52% of the estimated acetoacetate production rate.
Urinary excretion of acetone remained constant and accounted for about 7% of the acetone production rate in all patients.
There was a positive linear relationship between the percentage of the acetone production rate accounted for by excretion in breath and the plasma acetone concentration.
At low plasma acetone concentrations, ∼ 20%, and at high plasma acetone concentrations, ∼ 80% of the production rate was accounted for by breath acetone.
In contrast, there was a negative linear relationship between the percentage of acetone production rate undergoing in vivo metabolism and plasma acetone concentration.
At low plasma acetone concentrations, ∼ 75%, and at high concentrations, ∼ 20% of acetone production rate was accounted for by in vivo metabolism.
Radioactivity from 2-[14C]-acetone was variably present in plasma acetone, glucose, lipids and proteins.
No radioactivity was found in plasma acetoacetate, beta-hydroxy butyrate or free fatty acids or other anionic compounds.
Exchange rates of acetone into other metabolites could not be estimated because of non-steady-state precursor product relationships in these patients.
Related Results
Acetone Metabolism in Humans During Diabetic Ketoacidosis
Acetone Metabolism in Humans During Diabetic Ketoacidosis
Plasma acetone turnover rates were measured with the primed continuous infusion of 2-[14C]acetone in patients with moderate to severe diabetic ketoacidosis. Plasma acetone turnover...
Mortality and its predictors in Adult Diabetic ketoacidosis patients in East Africa: A 2025 Systematic review and meta-analysis
Mortality and its predictors in Adult Diabetic ketoacidosis patients in East Africa: A 2025 Systematic review and meta-analysis
Background Diabetes ketoacidosis occurs at an estimated rate between 4.6 and 8 episodes per 100 patient-years in individuals with diabetes. Up to 47% of diabetes-related ketoacidos...
Sodium-Glucose Cotransporter-2 Inhibitors in Odontogenic Infections
Sodium-Glucose Cotransporter-2 Inhibitors in Odontogenic Infections
On top of improving glycemic control, sodium-glucose cotransporter-2 inhibitors have been shown to reduce cardiovascular mortality & heart failure hospitalization. Sodium-gluco...
Sodium-Glucose Cotransporter-2 Inhibitors In Odontogenic Infections
Sodium-Glucose Cotransporter-2 Inhibitors In Odontogenic Infections
Abstract
On top of improving glycemic control, sodium-glucose cotransporter-2 inhibitors have been shown to reduce cardiovascular mortality & heart failure hospitalizat...
Renal biopsy in diabetic patients: Histopathological and clinical correlations
Renal biopsy in diabetic patients: Histopathological and clinical correlations
Introduction: Diabetes is the leading cause of chronic kidney disease and end-stage kidney disease worldwide. A kidney biopsy in a diabetic patient must be considered when non-diab...
SERUM VISFATIN, INSULIN RESISTANCE AND BETA CELL FUNCTION IN TYPE II DIABETIC PATIENTS AND NON-DIABETIC ADULT OFFSPRING WITH POSITIVE PARENTAL HISTORY OF TYPE II DIABETES MELLITUS
SERUM VISFATIN, INSULIN RESISTANCE AND BETA CELL FUNCTION IN TYPE II DIABETIC PATIENTS AND NON-DIABETIC ADULT OFFSPRING WITH POSITIVE PARENTAL HISTORY OF TYPE II DIABETES MELLITUS
Introduction:
Non-diabetic individuals with type II diabetic parents are more susceptible to develop Diabetes. Visfatin; an adipocytokine and an enzyme is linked with glucose...
Recognizing the Gap: A Case Series of Euglycemic and Hyperglycemic SGLT2 Inhibitor-Associated Diabetic Ketoacidosis
Recognizing the Gap: A Case Series of Euglycemic and Hyperglycemic SGLT2 Inhibitor-Associated Diabetic Ketoacidosis
Introduction: Ketoacidosis is a rare but serious side effect of sodium-glucose cotransporter-2 inhibitors (SGLT2i), possibly overlooked in clinical practice. We aim to further char...
FREQUENCY OF FACTORS LEADING TO DEVELOPING OF DIABETES KETOACIDOSIS IN PATIENTS WITH TYPE 1 DIABATES
FREQUENCY OF FACTORS LEADING TO DEVELOPING OF DIABETES KETOACIDOSIS IN PATIENTS WITH TYPE 1 DIABATES
Background: Diabetic ketoacidosis (DKA) is a serious, acute complication of type 1 diabetes mellitus, characterized by hyperglycemia, metabolic acidosis, and ketonemia. Despite adv...

